John R. Perkins II

This profile gathers the share dealings of John R. Perkins II in Talecris Biotherapeutics Holdings Corp. In total, 10 filings cover trades dated from 30 September 2009 to 1 June 2011.

Sales make up the whole of the open-market record (2 sales, €4.3M). Outside the open market, there are 4 share grants and 3 option exercises.

On 3 June 2011 came the latest disclosure, a transaction in Talecris Biotherapeutics Holdings Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.